Overview

Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation

Status:
Completed
Trial end date:
2021-04-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the dose response, safety, and efficacy of linaclotide when compared with placebo in pediatric participants, 2 to 5 years of age, with Functional Constipation.
Phase:
Phase 2
Details
Lead Sponsor:
Allergan
Collaborator:
Ironwood Pharmaceuticals, Inc.
Treatments:
Linaclotide